- Home
- CBUS vs CRVO Comparison
CBUS vs CRVO Comparison
Compare CBUS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- CRVO
- Stock Information
- Founded
- CBUS 2010
- CRVO 2001
- Country
- CBUS United States
- CRVO United States
- Employees
- CBUS N/A
- CRVO N/A
- Industry
- CBUS Agricultural Chemicals
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- CRVO Health Care
- Exchange
- CBUS Nasdaq
- CRVO Nasdaq
- Market Cap
- CBUS 69.9M
- CRVO 71.1M
- IPO Year
- CBUS 2017
- CRVO N/A
- Fundamental
- Price
- CBUS $1.34
- CRVO $8.80
- Analyst Decision
- CBUS Strong Buy
- CRVO Strong Buy
- Analyst Count
- CBUS 2
- CRVO 6
- Target Price
- CBUS $21.25
- CRVO $21.50
- AVG Volume (30 Days)
- CBUS 172.9K
- CRVO 79.5K
- Earning Date
- CBUS 11-13-2025
- CRVO 11-10-2025
- Dividend Yield
- CBUS N/A
- CRVO N/A
- EPS Growth
- CBUS N/A
- CRVO N/A
- EPS
- CBUS N/A
- CRVO N/A
- Revenue
- CBUS $3,794,000.00
- CRVO $6,159,786.00
- Revenue This Year
- CBUS $17.67
- CRVO N/A
- Revenue Next Year
- CBUS $63.43
- CRVO N/A
- P/E Ratio
- CBUS N/A
- CRVO N/A
- Revenue Growth
- CBUS N/A
- CRVO N/A
- 52 Week Low
- CBUS $1.09
- CRVO $1.80
- 52 Week High
- CBUS $4.96
- CRVO $16.94
- Technical
- Relative Strength Index (RSI)
- CBUS 50.07
- CRVO 67.68
- Support Level
- CBUS $1.24
- CRVO $7.51
- Resistance Level
- CBUS $1.39
- CRVO $9.45
- Average True Range (ATR)
- CBUS 0.10
- CRVO 0.57
- MACD
- CBUS -0.00
- CRVO 0.24
- Stochastic Oscillator
- CBUS 90.00
- CRVO 82.33
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.